OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
1306 Publications
found
Evaluation of a new insulinotropic agent by using an innovative technology: efficacy and safety of nateglinide determined by continuous glucose monitoring.
b
Diabetes technology & therapeutics
February 1, 2004
p
Diabetes
c
Change patient management
Observational
Role of C-reactive protein in deciding duration of antibiotic therapy in neonatal septicemia.
b
Indian pediatrics
September 1, 2003
p
Antibiotic Guidance
c
Change patient management
Observational
BNP in hormone-guided treatment of heart failure.
b
Trends in endocrinology and metabolism: TEM
January 1, 2002
p
Cardiovascular Disease
c
Change patient management
Clinical outcomes
RCT
[A randomized controlled trial of the use of CRP rapid test as a guide to treatment of respiratory infections in general practice].
b
Ugeskrift for laeger
July 2, 2001
p
Antibiotic Guidance
c
Change patient management
Clinical outcomes
RCT
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.
b
Lancet (London, England)
April 1, 2000
p
Cardiovascular Disease
c
Change patient management
Clinical outcomes
RCT
Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice.
b
Scandinavian journal of primary health care
March 1, 2000
p
Antibiotic Guidance
c
Change patient management
Clinical outcomes
RCT
Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes.
b
Clinical chemistry
April 1, 1999
p
Antibiotic Guidance
c
Change patient management
Operational efficiencies
RCT
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
b
Lancet (London, England)
September 12, 1998
p
Diabetes
c
Change patient management
Clinical outcomes
Operational efficiencies
RCT
C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection.
b
Pediatrics
February 1, 1997
p
Antibiotic Guidance
c
Change patient management
Clinical outcomes
RCT
[The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults].
b
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
May 20, 1995
p
Antibiotic Guidance
c
Change patient management
RCT
Previous Page
1
…
128
129
130
131
Next Page